Abstract
With the advent of transcatheter aortic valve implantation (TAVI) techniques, a renewed interest has developed in sutureless aortic valve concepts in the last decade. The main feature of sutureless aortic valve implantation is the speed of insertion, thus making implantation easier for the surgeon. As a result, cross clamp times and myocardial ischemia may be reduced. The combined procedures (CABG with AVR in particular) can be done with a short cross clamp time. Perceval valve also provides an increased effective orifice area as compared with a stented bioprosthesis. Sutureless implantation of the Perceval valve is not only associated with shorter cross-clamp and cardiopulmonary bypass times but improved clinical outcomes too. This review covers the sutureless aortic valves and their evolution, with elaborate details on Perceval S valve in particular (which is the most widely used sutureless valve around the globe).
Keywords: Aortic valve, bioprosthesis, Perceval valve, TAVI.
Graphical Abstract
[1]
Bridgewater B, Gummert J, Kinsman R, Walton P. Towards global benchmarking: the Fourth EACTS Adult Cardiac Surgical Database Report. Oxfordshire: Dendrite Clinical Systems;. 2010. Henley-on-Thames.
[2]
Al-Sarraf N, Thalib L, Hughes A, et al. Cross-clamp time is an independent predictor of mortality and morbidity in low and high-risk cardiac patients. Int J Surg 2011; 9(1): 104-9.
[3]
Berreklouw E, Vogel B, Fischer H, et al. Fast sutureless implantation of mechanical aortic valve prostheses using Nitinol attachment rings: Feasibility in acute pig experiments. J Thorac Cardiovasc Surg 2007; 134(6): 1508-12.
[4]
Santarpino G, Pfeiffer S, Concistré G, Grossmann I, Hinzmann M, Fischlein T. The perceval s aortic valve has the potential of shortening surgical time: does it also result in improved outcome? Ann Thorac Surg 2013; 96(1): 77-82.
[5]
Shrestha M, Maeding I, Höffler K, et al. Aortic valve replacement in geriatric patients with small aortic roots: are sutureless valves the future? Interact Cardiovasc Thorac Surg 2013; 17(5): 778-82.
[6]
Santarpino G, Pfeiffer S, Concistrè G, Fischlein T. Perceval S aortic valve implantation in mini-invasive surgery: the simple sutureless solution. Interact Cardiovasc Thorac Surg 2012; 15(3): 357-60.
[7]
Magovern GJ, Cromie HW. Sutureless prosthetic heart valves. J Thorac Cardiovasc Surg 1963; 46: 726-36.
[8]
Scott SM, Sethi GK, Flye MW, Takaro T. The sutureless aortic valve prosthesis: experience with and technical considerations for replacement of the early model. Ann Surg 1976; 184: 174-8.
[9]
Cribier A, Eltchaninoff H, Bash A, et al. Trans-catheter implantation of balloon-expandable prosthetic heart valves. Early results in an animal model. Circulation 2001; 104(Suppl. 2): I552.
[10]
Boudjemline Y, Bonhoeffer P. Steps toward percutaneous aortic valve replacement. Circulation 2002; 105: 775-8.
[11]
Webb JG, Munt B, Makkar R, Naqvi T, Dang N. A percutaneous stent-mounted valve for treatment of aortic or pulmonary valve disease. Catheter Cardiovasc Interv 2004; 63: 89-93.
[12]
Grube E, Laborde JC, Zickmann B, et al. First report on a human percutaneous transluminal implantation of a self-expanding valve prosthesis for interventional treatment of aortic valve stenosis. Catheter Cardiovasc Interv 2005; 66: 465-9.
[13]
Zannis K, Folliguet T, Laborde F. New sutureless aortic valve prosthesis: another tool in less invasive aortic valve replacement. Curr Opin Cardiol 2012; 27(2): 125-9.
[14]
Joudinaud TM, Flecher EM, Curry JW, Kegel CL, Weber PA, Duran CM. Sutureless stented aortic valve implantation under direct vision: lessons from a negative experience in sheep. J Card Surg 2007; 22: 13-7.
[15]
Quaden R, Attmann T, Boening A, Cremer J, Lutter G. Percutaneous aortic valve replacement: resection before implantation. Eur J Cardiothorac Surg 2005; 27: 836-40.
[16]
Webb JG, Pasupati S, Humphries K, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007; 14(116): 755-63.
[17]
Thiene G, Basso C, Della Barbera M, Valente M. Pericardial leaflet injury in transcatheter aortic valve implantation: trick or treat. Eur J Cardiothorac Surg 2011; 40(1): 259-60.
[18]
Subramanian S, Rastan AJ, Holzhey D, et al. Conventional aortic valve replacement in transcatheter aortic valve implantation candidates: a 5-year experience. Ann Thorac Surg 2012; 94: 726-30.
[19]
Wendt D, Thielmann M, Pizanis N, Jánosi RA, Kamler M, Jakob H. Sutureless aortic valves over the last 45 years. Minim Invasive Ther Allied Technol 2009; 18(3): 122-30.
[20]
Gott VL, Alejo DE, Cameron DE. Mechanical heart valves: 2. 50 years of evolution. Ann Thorac Surg 2003; 76: S2230-9.
[21]
Magovern GJ, Liebler GA, Park SB, Burkholder JA, Sakert T, Simpson KA. Twenty-five-year review of the Magovern-Cromie sutureless aortic valve Ann Thorac Surg. 1989. 48(3 Suppl): S33-4-
60.
[22]
Scott SM, Sethi GK, Flye MW, Takaro T. The sutureless aortic valve prosthesis: experience with and technical considerations for replacement of the early model. Ann Surg 1976; 184(2): 174-8.
[23]
Wendt D, Thielmann M, Buck T, et al. First clinical experience and 1-year follow-up with the sutureless 3F-Enable aortic valve prosthesis. Eur J Cardiothorac Surg 2008; 33(4): 542-7.
[24]
Leyh R, Yildirim C, Buck T, Sommer S, Herold U, Jakob H. Early single-center experience with the 3F-enable aortic valve bioprosthesis. Herz 2006; 31(5): 423-8.
[25]
Martens S, Sadowski J, Eckstein FS. Clinical experience with the ATS 3f Enable [REGISTERED] Sutureless Bioprosthesis. Eur J Cardiothorac Surg 2011; 40(3): 749-55.
[26]
Sadowski J, Kapelak B, Pfitzner R, et al. Sutureless aortic valve bioprothesis ‘3F/ATS Enable’--4.5 years of a single-centre experience. Kardiol Pol 2009; 67: 956-63.
[27]
Breitenbach I, Wimmer-Greinecker G, Bockeria LA. Sutureless aortic valve replacement with the Trilogy Aortic Valve System: multicenter experience. J Thorac Cardiovasc Surg 2010; 140(4): 878-84.
[28]
Shrestha M, Folliguet T, Meuris B, et al. Sutureless Perceval S aortic valve replacement: a multicenter, prospective pilot trial. J Heart Valve Dis 2009; 18(6): 698-702.
[29]
Shrestha M, Folliguet T, Meuris B, et al. Sutureless Perceval S aortic valve replacement: a multicenter, prospective pilot trial. J Heart Valve Dis 2009; 18(6): 698-702.
[30]
Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet 2006; 368: 1005-11.
[31]
Lindroos M, Kupari M, Heikkila J, et al. Prevalence of aortic valve abnormalilites in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol 1993; 21: 1220-5.
[32]
Al-Sarraf N, Thalib L, Hughes A, et al. Cross-clamp time is an independent predictor of mortality and morbidity in low- and high-risk cardiac patients. Int J Surg 2011; 9(1): 104-9.
[33]
Flameng W, Herregods MC, Hermans H, et al. Effect of sutureless implantation of the Perceval S aortic valve bioprosthesis on intraoperative and early postoperative outcomes. J Thorac Cardiovasc Surg 2011; 142: 1453-7.
[34]
Santarpino G, Pfeiffer S, Concistré G, Grossmann I, Hinzmann M, Fischlein T. The Perceval S aortic valve has the potential of shortening surgical time: does it also result in improved outcome? Ann Thorac Surg 2013; 96(1): 77-81.
[35]
Phan K, Tsai Y-C, Niranjan N, Yan TD, Di Eusanio M. Sutureless aortic valve replacement: a systematic review and meta-analysis. Ann Cardiothorac Surg 2014.
[http://dx.doi.org/10.3978/j.issn.2225-319X.2014.06.01]
[http://dx.doi.org/10.3978/j.issn.2225-319X.2014.06.01]
[36]
Varadarajan P, Kapoor N, Bansal RC, et al. Clinical profile and natural history of 453 nonsurgically managed patients with severe aortic stenosis. Ann Thorac Surg 2006; 82: 2111-5.
[37]
Bouma BJ, van Den Brink RB, van der Meulen JH, et al. To operate or not on elderly patients with aortic stenosis: the decision and its consequences. Heart 1999; 82: 143-8.
[38]
Laborde JC, Brecker SJ, Roy D, Jahangiri M. Complications at the Time of Transcatheter Aortic Valve Implantation. Methodist DeBakey Cardiovasc J 2012; 8(2): 38-41.
[39]
Kodali SK, Williams MR, Smith CR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 2012; 366: 1686-95.
[40]
Kocher AA, Laufer G, Haverich A, et al. One-year outcomes of the Surgical Treatment of Aortic Stenosis With a Next Generation Surgical Aortic Valve (TRITON) trial: a prospective multicenter study of rapid-deployment aortic valve replacement with the EDWARDS INTUITY Valve System. J Thorac Cardiovasc Surg 2013; 145: 110-5.
[41]
D’Onofrio A, Messina A, Lorusso R, et al. Sutureless aortic valve replacement as an alternative treatment for patients belonging to the “gray zone” between transcatheter aortic valve implantation and conventional surgery: a propensity-matched, multicenter analysis. J Thorac Cardiovasc Surg 2012; 144: 1010-6.
[42]
Folliguet TA, Laborde F, Zannis K, Ghorayeb G, Haverich A, Shrestha M. Shrestha. Sutureless Perceval aortic valve replacement: results of two European centers. Ann Thorac Surg 2012; 93: 1483-8.
[43]
Concistrè G1, Santarpino G, Pfeiffer S, et al. Two alternative sutureless strategies for aortic valve replacement: a two-center experience. Innovations (Phila) 2013; 8: 253-7.
[44]
Santarpino G, Pfeiffer S, Jessl J, et al. Sutureless replacement versus transcatheter valve implantation in aortic valve stenosis: a propensity-matched analysis of 2 strategies in high-risk patients. J Thorac Cardiovasc Surg 2014; 147(2): 561-7.
[45]
Phan K, Tsai Y-C, Niranjan N, Yan TD, Di Eusanio M. Sutureless aortic valve replacement: a systematic review and meta-analysis. Ann Cardiothorac Surg 2014.
[http://dx.doi.org/10.3978/j.issn.2225-319X.2014.06.01]
[http://dx.doi.org/10.3978/j.issn.2225-319X.2014.06.01]
[46]
Cao C, Ang SC, Indraratna P, et al. Systematic review and meta-analysis of transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis. Ann Cardiothorac Surg 2013; 2: 10-23.
Article Metrics
27
2